Axes 1–2
Traceability and studiedness
Scored from the available data. Identity: Only the species or an unresolved identity is available. Quantity disclosure: 100.0%. Potency: Potency is stated at manufacture.
product · release 2026-09-20
Royal Guard 2-Phase Dual Immune Booster
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Organisms, fibers and substances on this label
Printed organisms · observed
Organism list
Quantities reflect printed organism rows.
| Printed name and notes | Normalized organism | Printed code | Printed deposit | Printed quantity | Flags |
|---|---|---|---|---|---|
| Lactobacillus acidophilus | Lactobacillus acidophilus | not printed | not printed | 1,330,000 CFU | T4; observed; quantity printed |
Pack, dose and cost
What the label says beyond the organisms
- Pack
- 30 Individual Pack(s) · Tablet or Pill
- Serving
- 1 Tablet(s) · 1 serving(s) a day
- Days of supply
- not computable: the pack is printed in Individual Pack(s) and the serving in Tablet(s)
- Potency per day
- 1,330,000 CFU
- Cost per day
- no observed price in this release
- Printed claims
- 2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
- Other ingredients
- 7 printed: Microcrystalline Cellulose, Hydroxypropyl Methylcellulose, Stearic Acid, Magnesium Stearate, natural colors, Silica, Pharmaceutical Glaze
- Label target groups
- Vegetarian, Adult (18 - 50 Years), No Allergies, Gluten Free, Dairy Free
- Suggested use
- DIRECTIONS: As a dietary supplement, take one pack daily.
- UPC
- 8 79610 00051 5
Printed potency
Quantity on the label
1,330,000 CFU per serving across 1 of 1 printed organism rows; potency basis Potency is stated at manufacture.
Evidence behind the label
Located human trials per organism
| Organism on this label | PubMed records indexed as human randomized controlled trials |
|---|---|
| Arabinogalactan | 13 |
| Lactobacillus acidophilus | 381 |
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 88.4% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
A150.00
A2100.00
GIS77.50
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 63.97–80.25; rank uncertainty 307.00–1410.00; rank class 1.
Versions
Typed label snapshot edges
No typed edge in this release.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Strain dose match · Supplier code network
Tools: Unit value calculator · DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). Royal Guard 2-Phase Dual Immune Booster. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/2-phase-dual-immune-booster/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Royal Guard 2-Phase Dual Immune Booster: 0 of 1 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 15515. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed organisms · NIH DSLD snapshot Sep 2026 · product.organisms · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Royal Guard 2-Phase Dual Immune Booster: 1 of 1 observed label snapshots state a potency basis; latest basis is at manufacture. Quantities reflect printed organism rows. Window: NIH DSLD snapshot Sep 2026.
1 / 1 observed label snapshots · NIH DSLD snapshot Sep 2026 · product.potency · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Royal Guard 2-Phase Dual Immune Booster: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 77.50 on the 100-point scale; rank class 1 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
1 / 1 selected label snapshots · NIH DSLD snapshot Sep 2026 · product.gis · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Royal Guard 2-Phase Dual Immune Booster has 1 observed versions across 1 formulation groups; last recorded edge type: no typed edge. Window: NIH DSLD snapshot Sep 2026.
1 / 1 formulation groups · NIH DSLD snapshot Sep 2026 · product.versions · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Royal Guard 2-Phase Dual Immune Booster: 0 of 1 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.
0 / 1 observed label versions · NIH DSLD snapshot Sep 2026 · product.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437